Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, oncology, and dermatology in various dosage forms, including injectables, solid orals, liquid orals, and topicals.
Sai Parenteral's Limited (SAIPARENT) is listed on the NSE in the Healthcare sector, Drug Manufacturers - General industry. The SAIPARENT share price is ₹483.15 (+0.04% today), with a market capitalisation of ₹21B and a price-to-earnings (P/E) ratio of 85.7. MarketRipple tracks the SAIPARENT investment thesis, the ripple-chain impact of market events on Sai Parenteral's Limited, and the Healthcare sector outlook.
Open
₹469.10
High
₹484.95
Low
₹467.80
Prev. Close
₹482.95
52W High
₹706.00
52W Low
₹400.00
Day range
₹467.80–₹484.95
52-week range
₹400.00–₹706.00
Volume
34K
P/E
85.7
ROE
2.9%
D/E
0.96
Margin
3.7%
Sai Parenteral's Limited (NSE: SAIPARENT) is currently trading at ₹483.15 (+0.04%).
Sai Parenteral's Limited's market capitalization is ₹21B.
Sai Parenteral's Limited's price-to-earnings (P/E) ratio is 85.7.
Sai Parenteral's Limited operates in the Healthcare sector (Drug Manufacturers - General).